In this review, we synthesise evidence from human lung tissue, experimental models, lipidomic analyses, and clinical investigations to place macrophage populations described in IPF-including FABP4-high homeostatic cells and SPP1-associated disease-enriched states-within a unified lipid-metabolic context. The gene discussed is FABP4; the disease is idiopathic pulmonary fibrosis.